Center for Genomic Medicine, Harvard Medical School, Boston, United States; Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, United States
Marissa A Andrew
Center for Genomic Medicine, Harvard Medical School, Boston, United States
Jason St Claire
Center for Genomic Medicine, Harvard Medical School, Boston, United States
Melissa Shaughnessey
Center for Genomic Medicine, Harvard Medical School, Boston, United States
Leroy Hubert
Verna and Marrs McLean Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, United States
Center for Genomic Medicine, Harvard Medical School, Boston, United States
Ricardo Mouro Pinto
Center for Genomic Medicine, Harvard Medical School, Boston, United States; Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, United States
Center for Genomic Medicine, Harvard Medical School, Boston, United States; Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, United States
John H Wilson
Verna and Marrs McLean Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, United States
Michael E Talkowski
Center for Genomic Medicine, Harvard Medical School, Boston, United States; Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, United States; Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, United States
Center for Genomic Medicine, Harvard Medical School, Boston, United States; Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, United States
Somatic expansion of the Huntington’s disease (HD) CAG repeat drives the rate of a pathogenic process ultimately resulting in neuronal cell death. Although mechanisms of toxicity are poorly delineated, transcriptional dysregulation is a likely contributor. To identify modifiers that act at the level of CAG expansion and/or downstream pathogenic processes, we tested the impact of genetic knockout, in HttQ111 mice, of Hdac2 or Hdac3 in medium-spiny striatal neurons that exhibit extensive CAG expansion and exquisite disease vulnerability. Both knockouts moderately attenuated CAG expansion, with Hdac2 knockout decreasing nuclear huntingtin pathology. Hdac2 knockout resulted in a substantial transcriptional response that included modification of transcriptional dysregulation elicited by the HttQ111 allele, likely via mechanisms unrelated to instability suppression. Our results identify novel modifiers of different aspects of HD pathogenesis in medium-spiny neurons and highlight a complex relationship between the expanded Htt allele and Hdac2 with implications for targeting transcriptional dysregulation in HD.